Latham & Watkins Advises Lexington Medical in Investment by Ampersand Capital Partners

Lexington Medical (Lexington), a leader in minimally invasive surgical stapling solutions, has announced a strategic investment by Ampersand Capital Partners (Ampersand), a private equity firm specializing in growth equity investments in the healthcare and life sciences sectors. The partnership underscores Ampersand’s confidence in Lexington’s potential to redefine surgical stapling standards and positions the company for accelerated growth in product innovation, smart manufacturing, and global market expansion.

Latham & Watkins LLP represents Lexington in the investment with an Emerging Companies & Growth team led by Boston partner Dan Hoffman, with associates Erik Thompson and Michael Pioso. Advice was also provided on tax matters by Bay Area partner Kirt Switzer, with associate Jeremiah Cowen.